Zhejiang Medicine Co Ltd
SSE:600216

Watchlist Manager
Zhejiang Medicine Co Ltd Logo
Zhejiang Medicine Co Ltd
SSE:600216
Watchlist
Price: 17.39 CNY -1.75% Market Closed
Market Cap: 16.7B CNY
Have any thoughts about
Zhejiang Medicine Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Zhejiang Medicine Co Ltd

Current Assets 5.7B
Cash & Short-Term Investments 1.8B
Receivables 1.8B
Other Current Assets 2B
Non-Current Assets 7.2B
Long-Term Investments 247.4m
PP&E 6.1B
Intangibles 728.1m
Other Non-Current Assets 83.9m
Current Liabilities 2.1B
Accounts Payable 1.1B
Accrued Liabilities 142.4m
Short-Term Debt 270.9m
Other Current Liabilities 627.8m
Non-Current Liabilities 801.1m
Long-Term Debt 424.5m
Other Non-Current Liabilities 376.6m

Balance Sheet
Zhejiang Medicine Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 279
1 163
1 317
1 417
1 492
1 278
1 629
1 769
1 438
1 460
Cash
0
0
0
0
0
0
0
1 769
1 438
1 460
Cash Equivalents
1 279
1 163
1 317
1 417
1 492
1 278
1 629
0
0
0
Short-Term Investments
0
0
0
299
274
480
321
457
447
328
Total Receivables
1 244
1 325
1 469
1 796
1 741
1 795
1 648
1 872
1 675
1 685
Accounts Receivables
839
916
1 012
1 301
1 259
1 413
1 175
1 444
1 298
1 252
Other Receivables
405
409
457
495
482
382
473
428
377
433
Inventory
812
860
1 028
971
1 192
1 435
1 480
1 873
1 995
2 011
Other Current Assets
49
49
31
30
34
51
40
64
101
118
Total Current Assets
3 384
3 397
3 845
4 513
4 734
5 039
5 118
6 035
5 655
5 601
PP&E Net
3 675
4 070
4 203
4 423
4 460
4 496
4 556
5 422
5 673
6 066
PP&E Gross
3 675
4 070
4 203
4 423
4 460
4 496
4 556
5 422
5 673
6 066
Accumulated Depreciation
1 141
1 424
1 738
2 017
2 326
2 780
3 175
3 747
4 285
4 811
Intangible Assets
347
409
425
407
408
407
410
729
748
744
Goodwill
0
0
12
12
5
0
0
36
28
19
Long-Term Investments
438
348
299
369
367
315
299
226
242
261
Other Long-Term Assets
25
24
31
69
74
106
119
84
87
89
Other Assets
0
0
12
12
5
0
0
36
28
19
Total Assets
7 869
N/A
8 249
+5%
8 814
+7%
9 793
+11%
10 048
+3%
10 362
+3%
10 500
+1%
12 532
+19%
12 433
-1%
12 780
+3%
Liabilities
Accounts Payable
942
1 028
917
872
776
757
674
1 389
1 029
1 130
Accrued Liabilities
46
54
69
147
156
140
252
293
271
259
Short-Term Debt
159
367
335
324
426
674
275
274
91
228
Current Portion of Long-Term Debt
0
1
0
14
108
0
200
450
550
370
Other Current Liabilities
45
55
271
460
420
479
523
619
525
491
Total Current Liabilities
1 192
1 505
1 592
1 817
1 887
2 051
1 924
3 025
2 465
2 478
Long-Term Debt
0
20
135
120
12
0
501
251
201
231
Deferred Income Tax
56
47
40
29
22
23
11
21
2
0
Minority Interest
23
20
14
490
437
391
355
403
450
356
Other Liabilities
60
61
56
48
43
37
34
53
54
84
Total Liabilities
1 331
N/A
1 653
+24%
1 836
+11%
2 504
+36%
2 401
-4%
2 502
+4%
2 826
+13%
3 753
+33%
3 173
-15%
3 149
-1%
Equity
Common Stock
936
936
963
966
965
965
965
965
965
965
Retained Earnings
4 380
4 485
4 889
5 002
5 290
5 611
5 371
6 195
6 417
6 682
Additional Paid In Capital
910
910
1 090
1 279
1 349
1 343
1 398
1 692
1 941
2 005
Treasury Stock
0
0
188
125
82
60
60
60
58
28
Other Equity
313
264
225
167
125
1
0
14
5
6
Total Equity
6 538
N/A
6 595
+1%
6 978
+6%
7 289
+4%
7 647
+5%
7 861
+3%
7 675
-2%
8 779
+14%
9 260
+5%
9 631
+4%
Total Liabilities & Equity
7 869
N/A
8 249
+5%
8 814
+7%
9 793
+11%
10 048
+3%
10 362
+3%
10 500
+1%
12 532
+19%
12 433
-1%
12 780
+3%
Shares Outstanding
Common Shares Outstanding
936
936
936
966
958
958
958
958
958
962

See Also

Discover More